Max Velocity Tactical



Your Ad Here - Email for Info

You Can Shop At Amazon and Help Support Emergency-Preps.com Without It Costing You One Thin Dime - Click Here to Learn How!

Author Topic: DARPA FOAM (Medical - internal)  (Read 542 times)

0 Members and 1 Guest are viewing this topic.

Offline Ken

  • Hero Member
  • *****
  • Posts: 1008
  • Karma: +8/-0
  • Gender: Male
DARPA FOAM (Medical - internal)
« on: December 12, 2012, 03:46:37 PM »
http://www.darpa.mil/NewsEvents/Releases/2012/12/10.aspx

DARPA FOAM COULD INCREASE SURVIVAL RATE FOR VICTIMS OF INTERNAL HEMORRHAGING


December 10, 2012

Technology developed under DARPA’s Wound Stasis System program resulted in 72 percent survival rate at three hours post-injury in testing   

The Department of Defense’s medical system aspires to a standard known as the “Golden Hour” that dictates that troops wounded on the battlefield are moved to advanced-level treatment facilities within the first 60 minutes of being wounded. In advance of transport, initial battlefield medical care administered by first responders is often critical to injured servicemembers’ survival. In the case of internal abdominal injuries and resulting internal hemorrhaging, however, there is currently little that can be done to stanch bleeding before the patients reach necessary treatment facilities; internal wounds cannot be compressed the same way external wounds can, and tourniquets or hemostatic dressings are unsuitable because of the need to visualize the injury. The resulting blood loss often leads to death from what would otherwise be potentially survivable wounds.

DARPA launched its Wound Stasis System program in 2010 in the hopes of finding a technological solution that could mitigate damage from internal hemorrhaging. The program sought to identify a biological mechanism that could discriminate between wounded and healthy tissue, and bind to the wounded tissue. As the program evolved, an even better solution emerged: Wound Stasis performer Arsenal Medical, Inc. developed a foam-based product that can control hemorrhaging in a patient’s intact abdominal cavity for at least one hour, based on swine injury model data. The foam is designed to be administered on the battlefield by a combat medic, and is easily removable by doctors during surgical intervention at an appropriate facility, as demonstrated in testing.   

 http://www.youtube.com/watch?v=pT1d6jxKwpk&list=UUOIHBHRbvncMo7Bf0Vx1zEQ&index=1

Wound Stasis performers presented pre-clinical data on the foam treatment at the 2012 Annual Meeting of the American Association for the Surgery of Trauma in Kauai, Hawaii. These data demonstrated the ability of the foam to treat severe hemorrhage for up to three hours in a model of lethal liver injury. During testing, minimally invasive application of the product reduced blood loss six-fold and increased the rate of survival at three hours post-injury to 72 percent from the eight percent observed in controls.

“Potentially, Wound Stasis provides an important addition to our ability to save life and limb. Getting after these heretofore difficult-to-stabilize, if not untreatable wounds, expands our options and effectively extends the ‘Golden Hour,’” said Maj. Gen. Bill Hix, Director of Concept Development for the Army Capability Integration Center at Training and Doctrine Command. “A capability like this is important in any operation, but would prove vital during operations in austere areas where military resources and infrastructure are at a premium,” he said.

“Wound Stasis has been an exciting program because we were able to move unexpectedly from fundamental research to a pre-clinical proof-of-concept based on the strength of our findings,” said Brian Holloway, DARPA program manager. “According to the U.S. Army Institute of Surgical Research, internal hemorrhage is the leading cause of potentially survivable deaths on the battlefield, so the Wound Stasis effort should ultimately translate into an increased rate of survival among warfighters. If testing bears out, the foam technology could affect up to 50 percent of potentially survivable battlefield wounds. We look forward to working with the U.S. Food and Drug Administration on future regulatory submission of this device, and with our partners, the Army Institute of Surgical Research and Special Operations Command, on getting this technology to where it’s desperately needed on the front lines.”

The foam is actually a polyurethane polymer that forms inside a patient’s body upon injection of two liquid phases, a polyol phase and an isocyanate phase, into the abdominal cavity. As the liquids mix, two reactions are triggered. First, the mixed liquid expands to approximately 30 times its original volume while conforming to the surfaces of injured tissue. Second, the liquid transforms into solid foam capable of providing resistance to intra-abdominal blood loss. The foam can expand through pooled and clotted blood and despite the significant hydrostatic force of an active hemorrhage.

In tests, removal of the foam took less than one minute following incision by a surgeon. The foam was removed by hand in a single block, with only minimal amounts remaining in the abdominal cavity, and with no significant adherence of tissue to the foam. Features appearing in relief on the extracted foam showed conformal contact with abdominal tissues and partial encapsulation of the small and large bowels, spleen, and liver. Blood absorption was limited to near the surface of the foam; the inside of the foam block remained almost uniformly free of blood.

DARPA recently awarded a $15.5 million Phase II contract to Arsenal Medical to continue development of the treatment system and support regulatory submission. DARPA anticipates continuing the Wound Stasis program through at least FDA approval of a prototype device.

# # #

Associated images posted on www.darpa.mil and video posted at www.youtube.com/darpatv  may be reused according to the terms of the DARPA User Agreement, available here: http://go.usa.gov/nYr.
“If mankind is to survive, then throughout man’s history except for a very few years the word “ship” will mean “space ship.”
Arthur C. Clarke

Offline Langenator

  • Hero Member
  • *****
  • Posts: 1375
  • Karma: +17/-1
  • Gender: Male
Re: DARPA FOAM (Medical - internal)
« Reply #1 on: December 12, 2012, 06:38:03 PM »
So...it sounds kind of like Green Slime tire sealant, except for inside people.
Fortuna Fortis Paratus
“In the house of a wise man are stores of food, wine, and oil, but the foolish man devours all he has.” Proverbs 21:20
"We are content with discord, we are content with alarms, we are content with blood, but we will never be content with a master." -Pashtun malik, 1815


Offline Ken

  • Hero Member
  • *****
  • Posts: 1008
  • Karma: +8/-0
  • Gender: Male
Re: DARPA FOAM (Medical - internal)
« Reply #2 on: December 12, 2012, 10:41:02 PM »
So...it sounds kind of like Green Slime tire sealant, except for inside people.

Well....it is for leaking people....
“If mankind is to survive, then throughout man’s history except for a very few years the word “ship” will mean “space ship.”
Arthur C. Clarke

Offline Flight-ER-Doc

  • Hero Member
  • *****
  • Posts: 2251
  • Karma: +57/-7
  • Gender: Male
Re: DARPA FOAM (Medical - internal)
« Reply #3 on: December 13, 2012, 08:17:18 AM »
This is just a new take on an old idea - we have various types of clot supporting products, from plain old platlets to gauze to xerofoam to combat gauze to whatever.

If it works better than older products, great.  If it works about as well as existing products, it will be the next new thing, until something else comes along.

Until they have something better than an animation, however, I'll keep my combat gauze handy.
Yes, I'm a physician.  No, I'm not YOUR physician.  Nothing I say here is medical advice.

Do I treat Glocks like I treat my lawn mowers?  No, I treat them worse.  I treat my defensive weapons like my fire extinguishers and smoke detector - annual maintenance and I expect them to work when needed

Offline Ken

  • Hero Member
  • *****
  • Posts: 1008
  • Karma: +8/-0
  • Gender: Male
Re: DARPA FOAM (Medical - internal)
« Reply #4 on: December 13, 2012, 02:04:44 PM »
This is just a new take on an old idea - we have various types of clot supporting products, from plain old platlets to gauze to xerofoam to combat gauze to whatever.

If it works better than older products, great.  If it works about as well as existing products, it will be the next new thing, until something else comes along.

Until they have something better than an animation, however, I'll keep my combat gauze handy.

DARPA says it's in phase II, which means they are about to see if it can be made for a reasonable cost.  So it seems to be a bit better, than the usual, at least for now.

We will see.
“If mankind is to survive, then throughout man’s history except for a very few years the word “ship” will mean “space ship.”
Arthur C. Clarke


 

Related Topics

  Subject / Started by Replies Last post
1 Replies
548 Views
Last post November 08, 2010, 12:12:49 AM
by thebastidge
0 Replies
423 Views
Last post December 16, 2010, 09:04:47 PM
by Bill Quick
13 Replies
1280 Views
Last post October 11, 2011, 08:20:30 AM
by Coleman Junkie
0 Replies
130 Views
Last post October 20, 2011, 11:42:52 AM
by Bill Quick
12 Replies
1529 Views
Last post January 05, 2014, 11:58:28 PM
by oldguy52


Your Ad Here - Email for Info
Help Support E-P.com
Even A Buck Makes A Difference!
Or Make Convenient Monthly
Donations By Selecting
A Payment Option
Payment Options